Janku J - Search Results

1

Long-Term Efficacy, Safety, and Drug Survival of Guselkumab in Patients with Psoriasis: Real-World Data from the Czech Republic BIOREP Registry.

Hugo J, Kojanova M, Turkova B, Gkalpakiotis S; BIOREP Study Group. Hugo J, et al. Dermatol Ther (Heidelb). 2023 Mar;13(3):787-801. doi: 10.1007/s13555-023-00893-4. Epub 2023 Feb 1. Dermatol Ther (Heidelb). 2023. PMID: 36723775 Free PMC article.

2

New dual dye for vitreoretinal surgery with increased transparency.

Mohr A, Cendoya P, Wilinska J, Apostu M, Apostu E, Janku J, Wilfling T, Ramos G, Al-Joumhawy M, Gabel D. Mohr A, et al. Among authors: janku j. BMJ Open Ophthalmol. 2022 Sep;7(1):e001116. doi: 10.1136/bmjophth-2022-001116. BMJ Open Ophthalmol. 2022. PMID: 36161825 Free PMC article.

3

Scaffold polarity proteins Par3A and Par3B share redundant functions while Par3B acts independent of atypical protein kinase C/Par6 in podocytes to maintain the kidney filtration barrier.

Koehler S, Odenthal J, Ludwig V, Unnersjö Jess D, Höhne M, Jüngst C, Grawe F, Helmstädter M, Janku JL, Bergmann C, Hoyer PF, Hagmann HH, Walz G, Bloch W, Niessen C, Schermer B, Wodarz A, Denholm B, Benzing T, Iden S, Brinkkoetter PT. Koehler S, et al. Among authors: janku jl. Kidney Int. 2022 Apr;101(4):733-751. doi: 10.1016/j.kint.2021.11.030. Epub 2021 Dec 17. Kidney Int. 2022. PMID: 34929254

4

On the macrofinancial determinants of life and non-life insurance premiums.

Hodula M, Janků J, Časta M, Kučera A. Hodula M, et al. Among authors: janku j. Geneva Pap Risk Insur Issues Pract. 2021 Nov 25:1-39. doi: 10.1057/s41288-021-00249-z. Online ahead of print. Geneva Pap Risk Insur Issues Pract. 2021. PMID: 34848936 Free PMC article.

5

Real-World Evidence From More Than 1000 Patients Treated With Adalimumab For Moderate-to-Severe Psoriasis in the Czech Republic.

Kojanova M, Cetkovska P, Strosova D, Fialova J, Arenberger P, Dolezal T, Gkalpakiotis S; BIOREP Study Group. Kojanova M, et al. Dermatol Ther (Heidelb). 2021 Apr;11(2):543-553. doi: 10.1007/s13555-021-00499-8. Epub 2021 Mar 5. Dermatol Ther (Heidelb). 2021. PMID: 33666877 Free PMC article.

6

Characteristics and risk profile of psoriasis patients included in the Czech national registry BIOREP and a comparison with other registries.

Kojanova M, Fialova J, Cetkovska P, Gkalpakiotis S, Jircikova J, Dolezal T, Arenberger P; BIOREP study group. Kojanova M, et al. Int J Dermatol. 2017 Apr;56(4):428-434. doi: 10.1111/ijd.13543. Epub 2017 Feb 9. Int J Dermatol. 2017. PMID: 28181669

7

Structural requirements for inhibitors of cytochromes P450 2B: assessment of the enzyme interaction with diamondoids.

Hodek P, Bortek-Dohalská L, Sopko B, Sulc M, Smrcek S, Hudecek J, Janků J, Stiborová M. Hodek P, et al. Among authors: janku j. J Enzyme Inhib Med Chem. 2005 Feb;20(1):25-33. doi: 10.1080/14756360400024324. J Enzyme Inhib Med Chem. 2005. PMID: 15895681

8

Crop-specific human exposure assessment for polycyclic aromatic hydrocarbons in Czech soils.

Kulhánek A, Trapp S, Sismilich M, Janků J, Zimová M. Kulhánek A, et al. Among authors: janku j. Sci Total Environ. 2005 Mar 1;339(1-3):71-80. doi: 10.1016/j.scitotenv.2004.08.003. Sci Total Environ. 2005. PMID: 15740759

9

Probing the cytochrome P-450 2B1 active site with diamantoid compounds.

Hodek P, Burkhard J, Janků J. Hodek P, et al. Among authors: janku j. Gen Physiol Biophys. 1995 Jun;14(3):225-39. Gen Physiol Biophys. 1995. PMID: 8586256

10

Metabolism of diamantane by rat liver microsomal cytochromes P-450.

Hodek P, Janscák P, Anzenbacher P, Burkhard J, Janků J, Vodicka L. Hodek P, et al. Among authors: janku j. Xenobiotica. 1988 Oct;18(10):1109-18. doi: 10.3109/00498258809042233. Xenobiotica. 1988. PMID: 3242307

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

17 results

Search Page